Invitrogen™ Peptide synthétique H-cadherin humain
T-cadherin Synthetic Peptide, PEP-0277, from Invitrogen.
- Gene ID (Entrez)
- 1012
- Espèces
- Human
- Méthode de purification
- purified
- Numéro d’adhésion
- P55290
- Nom usuel
- Human H-cadherin
- Marque
- Invitrogen
T-cadherin Synthetic Peptide, PEP-0277, from Invitrogen.
T-cadherin Synthetic Peptide, PEP-0277, from Invitrogen.
The protein encoded by this gene has a C-terminal domain with tRNA 3 processing endoribonuclease activity, which catalyzes the removal of the 3' trailer from precursor tRNAs. The protein also interacts with activated Smad family member 2 (Smad2) and its nuclear partner forkhead box H1 (also known as FAST-1), and reduced expression can suppress transforming growth factor-beta induced growth arrest. Mutations in this gene result in an increased risk of prostate cancer. Multiple transcript variants encoding different isoforms have been found for this gene.
Espèces : Humaine.
Conservation : -20°C.
Concentration : 200 μg/mL.
Réservé à la recherche (RUO).
Conditionnement : 50 μg.
| Général | |
|---|---|
| Marque | Invitrogen |
| Réf. fournisseur (Fisher Scientific) | 15286489 |
| Caractéristiques | |
| Gene ID (Entrez) | 1012 |
| Espèces | Human |
| Méthode de purification | purified |
| Numéro d’adhésion | P55290 |
| Nom usuel | Human H-cadherin |
| Concentration | 200 μg/mL |
| Description | Synthetic Peptide |
| Format | Liquid |
| Formule | PBS with 0.1% BSA and 0.02% sodium azide; pH 7.2 |
| À utiliser avec (application) | Blocking Assay, Control |
| Symbole de gène(s) | CDH13 |
| Lyophilisé | No |
| Type de produit | Peptide |
| Quantité | 50 μg |
| État réglementaire | RUO - research use only |
| Stockage et expédition | |
| Contenu et stockage | -20°C |
| Conservateur | 0.02% sodium azide |
| Tampon de stockage | PBS |
| Réf. fabricant | PEP-0277 |
|---|---|
| Pays d’origine | États-Unis |
| Code douanier (SH) | 3824 99 96 00 |